OncoSec adds director | S&P Global Market Intelligence

Workflow Solutions
Products
See more S&P Global Solutions
See More IHS Markit Solutions
Content
How We Can Help
See More
News & Insights Topics
See More
Featured Events
In PersonPolitics & Policy: Market Impacts and Mid-Year Outlooks
- 06/24/2022
- Sofitel Washington DC Lafayette Square
- 8:30 AM – 12:00 PM ET
Webinar ReplaysExpand Your Perspective: Unlocking Insights Across the Supply Chain
- 05/11/2022
- On-Demand
- 1 Hour
Conference10th Annual Community Bankers Conference
- 05/16/2022
- Four Seasons Resort and Club, Dallas at Las Colinas
- Dallas, Texas
Platforms
Other Products
- Leveraged Commentary and Data
- Research Online

OncoSec adds director

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Global M&A By the Numbers: Q1 2022

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Investment Banking Essentials Newsletter April Edition - 2022

24 Dec, 2018

OncoSec adds director

Author Hassan Aftab
Theme Healthcare & Pharmaceuticals

OncoSec Medical Inc. appointed Joon Kim to its board.

Kim's appointment took place at the same time as the completion of Alpha Holdings Inc.'s $15 million investment in the company.

Kim serves a partner at Lee & Ko. Previously, he acted as a litigation lawyer and public prosecutor.

OncoSec Medical, based in San Diego and Pennington, N.J., develops treatments for cancer.